Margaret Hamburg

Margaret Hamburg is an American physician and public health administrator who served as the 21st Commissioner of Food and Drugs from 2009 to 2015. Appointed by President Barack Obama, she led the Food and Drug Administration (FDA) during a period of significant transformation, emphasizing regulatory science, global engagement, and food safety modernization. Her career has spanned academic medicine, local public health leadership in New York City, and biosecurity policy at the federal level, establishing her as a prominent figure in American and global health.

Early life and education

Born in Chicago, she is the daughter of renowned psychiatrists Beatrix Hamburg and David A. Hamburg. Her family's deep commitment to medicine and public service influenced her career path from an early age. She earned her Bachelor of Arts degree from Harvard College, graduating magna cum laude, and subsequently received her Doctor of Medicine from Harvard Medical School. She completed her internship and residency in internal medicine at what is now NewYork-Presbyterian/Weill Cornell Medical Center.

Medical and public health career

Following her clinical training, she moved into public health, focusing on infectious disease and biomedical research policy. She served as an assistant director at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). In 1991, she was appointed Commissioner of the New York City Department of Health and Mental Hygiene, where she pioneered innovative programs to combat tuberculosis and HIV/AIDS, and established the nation's first public health bioterrorism preparedness program. She later served as Assistant Secretary for Planning and Evaluation at the United States Department of Health and Human Services under the Clinton administration.

Commissioner of Food and Drugs

Nominated by President Barack Obama and confirmed by the United States Senate in 2009, her tenure at the Food and Drug Administration was marked by several major initiatives. She championed the FDA Food Safety Modernization Act (FSMA), the most significant overhaul of the U.S. food safety system in decades. She also advanced the Prescription Drug User Fee Act (PDUFA) and promoted the development of regulatory science to accelerate the evaluation of innovative medical products. During her leadership, the FDA addressed complex issues including tobacco regulation under the Family Smoking Prevention and Tobacco Control Act, the safety of medical devices, and the globalization of the drug supply chain.

Post-FDA career and other roles

After leaving the FDA in 2015, she was elected Foreign Secretary of the National Academy of Medicine, a position she held until 2022. She serves on the boards of directors of several major corporations, including Pfizer and IBM, and is a senior advisor to the Bill & Melinda Gates Foundation. She is also a founding member and co-chair of the Nuclear Threat Initiative's (NTI) Global Health Program, focusing on strengthening global health security and biosecurity. In 2022, she was appointed by the World Health Organization as Chair of the new WHO Science Council.

Awards and honors

Her contributions have been recognized with numerous awards, including the Fellowship in the American Association for the Advancement of Science and the Woman of the Year award from Glamour magazine. She has received honorary doctorates from institutions such as Icahn School of Medicine at Mount Sinai and Northeastern University. She is also a member of the Council on Foreign Relations and the American Philosophical Society.

Category:1955 births Category:Living people Category:American physicians Category:United States government officials Category:Food and Drug Administration officials